You have 9 free searches left this month | to do more

Abiraterone

Abiraterone is a drug used to treat Prostate Cancer, Prostatic Neoplasms, and Adenocarcinoma of the Prostate. Abiraterone is being actively studied in 36 studies and prior, has been studied in 12.

Top SponsorsTop SitesTop Investigators
Dana-Farber Cancer InstituteDana-Farber Cancer InstituteAristotelis Bamias
Janssen Research & Development, LLCJewish General HospitalChristopher Sweeney, MBBS
AmgenMemorial Sloan Kettering Cancer CenterDeepak Kilari
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital
2021-02-08
Feb 8, 2021
N
Recruiting
  • Castrate Sensitive Prostate Cancer
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
I
Active, not recruiting
  • Prostate Cancer
  • Sao Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
2021-05-14
May 14, 2021
R
Completed
  • Prostate Cancer
  • abiraterone
  • Nijmegen, Netherlands
    Radboud UMC
2020-12-04
Dec 4, 2020
C
Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • Boston, Massachusetts
  • +2 more
2021-03-22
Mar 22, 2021
M
Recruiting
  • Prostate Cancer
  • Phoenix, Arizona
  • +7 more
2022-02-16
Feb 16, 2022
J
Recruiting
  • Castration-resistant Prostate Cancer
  • Coenzyme A Combined With Abiraterone
  • Abiraterone
  • Wuxi, Jiangsu, China
    Jiangnan University
2021-04-08
Apr 8, 2021
U
Withdrawn
  • Prostatic Neoplasms, Castration-Resistant
  • (no location specified)
2020-11-15
Nov 15, 2020
D
Completed
  • Prostate Cancer
  • Boston, Massachusetts
  • +1 more
2021-08-05
Aug 5, 2021
U
Active, not recruiting
  • Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy
  • Abiraterone
  • Bordeaux, France
  • +4 more
2022-02-01
Feb 1, 2022
M
Recruiting
  • Prostate Cancer
  • Atlanta, Georgia
  • +1 more
2022-01-07
Jan 7, 2022
C
Completed
  • Prostate Cancer
  • Los Angeles, California
    Cedars Sinai Medical Center
2020-12-04
Dec 4, 2020
D
Active, not recruiting
  • Prostate Cancer
  • San Diego, California
  • +7 more
2022-03-07
Mar 7, 2022
C
Recruiting
  • Prostatic Neoplasms
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
2021-10-22
Oct 22, 2021
F
Recruiting
  • Prostate Cancer
  • +2 more
  • Abiraterone
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
2021-12-27
Dec 27, 2021
A
Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • San Diego, California
  • +40 more
2022-01-13
Jan 13, 2022
U
Suspended
  • Prostate Adenocarcinoma
  • +2 more
  • Positron Emission Tomography
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-02-09
Feb 9, 2022
M
Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • +2 more
  • Tucson, Arizona
  • +6 more
2021-10-05
Oct 5, 2021
U
Recruiting
  • Prostate Cancer
  • +2 more
  • Abiraterone
  • +4 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
2021-06-01
Jun 1, 2021
H
Active, not recruiting
  • Prostate Cancer
  • +3 more
  • Adaptive Androgen Deprivation Therapy (ADT)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
2021-12-27
Dec 27, 2021
M
Active, not recruiting
  • Prostate Cancer
  • Milwaukee, Wisconsin
    Froedtert Hospital
2021-02-17
Feb 17, 2021
V
Active, not recruiting
  • Newly Diagnosed Oligometastatic Prostate Cancer
  • radical prostatectomy
  • +4 more
  • Long Beach, California
  • +2 more
2022-03-16
Mar 16, 2022